CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myelomaTobias Bexte, Evelyn Ullrich, Lisa Marie Reindl et al.|OncoImmunology|2022Cited by 77
The MYC-Regulated RNA-Binding Proteins hnRNPC and LARP1 Are Drivers of Multiple Myeloma Cell Growth and Disease Progression and Negatively Predict Patient SurvivalMarcel Seibert, Ivana von Metzler|Cancers|2023Cited by 6